Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Timing for Liraglutide in Patients Remaining Obese at 6 Months After Metabolic Surgery
NCT07374445Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, sponsored by Nanjing Drum-Tower Hospital. Started Sep 2023; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07374445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07374445.